Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amneal Pharmaceuticals, Inc.

7.97
+0.23002.97%
Post-market: 7.81-0.1600-2.01%18:01 EDT
Volume:4.83M
Turnover:38.01M
Market Cap:2.50B
PE:-21.07
High:8.02
Open:7.79
Low:7.16
Close:7.74
Loading ...

Amneal Announces Expanded Coverage for Crexont® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.

THOMSON REUTERS
·
03 Apr

Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.

Business Wire
·
03 Apr

BUZZ-India's Shilpa Medicare gains on launch of new version of cancer drug

Reuters
·
03 Apr

Amneal Pharmaceuticals announces U.S. launch of Boruzu

TIPRANKS
·
01 Apr

Amneal Launches Boruzu™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma

THOMSON REUTERS
·
01 Apr

Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma

Business Wire
·
01 Apr

Amneal Pharmaceuticals (AMRX) Stock Soars 45% on Success of New Parkinson’s Treatment

TIPRANKS
·
18 Mar

Amneal to Participate at Upcoming Investor Conference

Business Wire
·
11 Mar

Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Sandoz Group Ltd (OtherSDZXF) and Medtronic (MDT)

TIPRANKS
·
10 Mar

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

StockStory
·
05 Mar

Amneal, mAbxience's Biologics Licensing Application for Denosumab Biosimilars Accepted for Review by FDA

MT Newswires Live
·
04 Mar

Amneal Pharmaceuticals BLA submissions for denosumab biosimilars accepted by FDA

TIPRANKS
·
04 Mar

BRIEF-Amneal’s BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA

Reuters
·
04 Mar

Amneal’s Bla Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA

THOMSON REUTERS
·
04 Mar

Amneal Pharma: Three More Biosimilars in Development

THOMSON REUTERS
·
04 Mar

Amneal Pharmaceuticals Inc - to Expand to Six Biosimilars by 2027

THOMSON REUTERS
·
04 Mar

Stock Track | Amneal Pharmaceuticals Soars 5.02% After Analysts Maintain Bullish Ratings

Stock Track
·
04 Mar

Truist Financial Sticks to Its Buy Rating for Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
03 Mar

Amneal Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
03 Mar

Amneal Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
01 Mar